Safety Alert: Class II: CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
healthClass IIRecalled on Sep 17, 2025
Chlorpromazine Hydrochloride Tablets, USP, 200 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi
🔢 N/A
Sold At: Zydus Pharmaceuticals (USA) Inc(Nationwide in the USA)
Recall #: FDA-DRUG-D-0638-2025
Source: FDA-ENFORCEMENT
Product Identification
- Lot/Batch Codes:
- Lot #: Z305083, Z305084, Z305468, Z305469, Z305470, Exp Date 30-09-25; Z401163, Z401165, Exp Date 28-02-26; Z402217, Z402218, Exp Date 31-03-26; Z405518, Z405520, Exp Date 31-08-26; Z406235, Exp Date 31-10-26
Get AI-Powered Summary
Premium members get instant insights to help you understand recalls faster
Instant 1-3 sentence summary
Quick action bullets
Clear guidance on what to do
Summary
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
What to do next
- 1Stop using this product - may cause temporary or medically reversible health problems
- 2Check with retailer or manufacturer for recall status and remedy options
- 3Contact Zydus Pharmaceuticals (USA) Inc for return or refund information
- 4Visit the official FDA recall page for complete details
Summaries only; always follow the official notice.